Literature DB >> 36273116

Prevalence of prediabetes and diabetes vary by ethnicity among U.S. Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study.

William S Vicks1, Joan C Lo2,3, Lynn Guo4, Jamal S Rana2,3,5, Sherry Zhang1, Nirmala D Ramalingam6, Nancy P Gordon7,8.   

Abstract

BACKGROUND: Asian adults develop Type 2 diabetes at a lower body mass index (BMI) compared to other racial/ethnic groups. We examined the variation in prevalence of prediabetes and diabetes among Asian ethnic groups within weight strata by comparing middle-aged Chinese, Filipino, South Asian, and White adults receiving care in the same integrated healthcare delivery system.
METHODS: Our retrospective cross-sectional U.S. study examined data from 283,110 (non-Hispanic) White, 33,263 Chinese, 38,766 Filipino, and 17,959 South Asian adults aged 45-64 years who were members of a Northern California health plan in 2016 and had measured height and weight. Prediabetes and diabetes were classified based on laboratory data, clinical diagnoses, or diabetes pharmacotherapy. Age-standardized prevalence of prediabetes and diabetes were compared by race/ethnicity within healthy weight, overweight, and obesity categories, using standard BMI thresholds for White adults (18.5 to < 25, 25 to < 30, ≥ 30 kg/m2) and lower BMI thresholds for Asian adults (18.5 to < 23, 23 to < 27.5, ≥ 27.5 kg/m2). Prevalence ratios (PRs) were used to compare the prevalence of diabetes and prediabetes for Asian groups to White adults in each weight category, adjusted for age and BMI.
RESULTS: Across all weight categories, diabetes prevalence was higher for Asian than White adults, and among Asian groups it was highest for Filipino and South Asian adults. Compared to White, PRs for South Asian men/women at healthy BMI were 1.8/2.8 for prediabetes and 5.9/8.0 for diabetes, respectively. The PRs for Filipino men/women at healthy BMI were 1.8/2.6 for prediabetes and 5.0/7.5 for diabetes, respectively. For Chinese men/women at healthy BMI, the PRs for prediabetes (2.1/2.9) were similar to Filipino and South Asian, but the PRs for diabetes were lower (2.1/3.4).
CONCLUSION: Chinese, Filipino, and South Asian adults have higher prevalence of prediabetes and diabetes than White adults in all weight categories, despite using lower BMI thresholds for weight classification in Asian groups. Within Asian ethnic groups, Filipino and South Asian adults had considerably higher diabetes prevalence than Chinese adults. Our data emphasize the disproportionate metabolic risk among middle-aged Asian adults and underscore the need for diabetes screening among high-risk Asian groups at healthy BMI levels.
© 2022. The Author(s).

Entities:  

Keywords:  Asian; Chinese; Diabetes; Filipino; Obesity; Prediabetes; South Asian; Weight

Year:  2022        PMID: 36273116     DOI: 10.1186/s12889-022-14362-8

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   4.135


  33 in total

Review 1.  Impaired fasting glucose and impaired glucose tolerance: implications for care.

Authors:  David M Nathan; Mayer B Davidson; Ralph A DeFronzo; Robert J Heine; Robert R Henry; Richard Pratley; Bernard Zinman
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

2.  Effect of Diabetes on Life Expectancy in the United States by Race and Ethnicity.

Authors:  Samuel H Preston; Daesung Choi; Irma T Elo; Andrew Stokes
Journal:  Biodemography Soc Biol       Date:  2018-12-20

3.  Spectrum of cardiovascular diseases inAsian-American racial/ethnic subgroups.

Authors:  Ariel T Holland; Eric C Wong; Diane S Lauderdale; Latha P Palaniappan
Journal:  Ann Epidemiol       Date:  2011-08       Impact factor: 3.797

4.  Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S.

Authors:  Yeyi Zhu; Margo A Sidell; David Arterburn; Matthew F Daley; Jay Desai; Stephanie L Fitzpatrick; Michael A Horberg; Corinna Koebnick; Emily McCormick; Caryn Oshiro; Deborah R Young; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2019-09-19       Impact factor: 19.112

5.  Type 2 diabetes: identifying high risk Asian American subgroups in a clinical population.

Authors:  Elsie J Wang; Eric C Wong; Anjali A Dixit; Stephen P Fortmann; Randolph B Linde; Latha P Palaniappan
Journal:  Diabetes Res Clin Pract       Date:  2011-06-12       Impact factor: 5.602

6.  Cardiovascular disease mortality in Asian Americans.

Authors:  Powell O Jose; Ariel T H Frank; Kristopher I Kapphahn; Benjamin A Goldstein; Karen Eggleston; Katherine G Hastings; Mark R Cullen; Latha P Palaniappan
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

7.  Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States.

Authors:  Priyanka Satish; Murrium I Sadaf; Javier Valero-Elizondo; Gowtham R Grandhi; Tamer Yahya; Hassan Zawahir; Zulqarnain Javed; Reed Mszar; Bashir Hanif; Ankur Kalra; Salim Virani; Miguel Cainzos-Achirica; Khurram Nasir
Journal:  Am J Prev Cardiol       Date:  2021-06-20

8.  Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study.

Authors:  Nancy P Gordon; Teresa Y Lin; Jyoti Rau; Joan C Lo
Journal:  BMC Public Health       Date:  2019-11-25       Impact factor: 3.295

9.  Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE).

Authors:  Andrew J Karter; Dean Schillinger; Alyce S Adams; Howard H Moffet; Jennifer Liu; Nancy E Adler; Alka M Kanaya
Journal:  Diabetes Care       Date:  2012-10-15       Impact factor: 19.112

10.  Projection of the future diabetes burden in the United States through 2060.

Authors:  Ji Lin; Theodore J Thompson; Yiling J Cheng; Xiaohui Zhuo; Ping Zhang; Edward Gregg; Deborah B Rolka
Journal:  Popul Health Metr       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.